Page last updated: 2024-08-18

pyrazolanthrone and Intestinal Diseases

pyrazolanthrone has been researched along with Intestinal Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boelsterli, UA; LoGuidice, A; Ramirez-Alcantara, V	1

Other Studies

1 other study(ies) available for pyrazolanthrone and Intestinal Diseases

Article	Year
Protection from diclofenac-induced small intestinal injury by the JNK inhibitor SP600125 in a mouse model of NSAID-associated enteropathy. American journal of physiology. Gastrointestinal and liver physiology, 2009, Volume: 297, Issue:5 Topics: Alkaline Phosphatase; Animals; Anthracenes; Apoptosis; Blood Proteins; Diclofenac; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred C57BL; Microvilli; Mitochondria; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-jun; Transcription Factor CHOP; Ulcer	2009

Article

Year

Protection from diclofenac-induced small intestinal injury by the JNK inhibitor SP600125 in a mouse model of NSAID-associated enteropathy.

American journal of physiology. Gastrointestinal and liver physiology, 2009, Volume: 297, Issue:5

Topics: Alkaline Phosphatase; Animals; Anthracenes; Apoptosis; Blood Proteins; Diclofenac; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred C57BL; Microvilli; Mitochondria; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-jun; Transcription Factor CHOP; Ulcer

2009